Neurotoxicity mechanism of Ochratoxin A

Main Article Content

Fahimeh Nourbakhsh
Elahe Tajbakhsh


brain; mycotoxins; neurotoxicity; Ochratoxin A


Mycotoxins, such as Ochratoxins, are widely distributed in nature and are common contaminants of human foodstuffs. Ochratoxins are a group of mycotoxins produced by a wide range of molds. Ochratoxin A (OTA), the most prominent member of this toxin family, is produced by various Aspergillus and Penicillium species. OTA is frequently found in foods such as cereals, oleaginous seeds, coffee, and meat products. This mycotoxin has been described as teratogenic, genotoxic, carcinogenic, and immunotoxic, and has been proven to be a potent neurotoxin. In the present study, the neurotoxicological perspective of OTA was reviewed and discussed. The main possible mechanisms of neurotoxicity are oxidative DNA, protein and lipid damage, and apoptosis. However, further studies are needed to conclude the exact neurotoxicity mechanism of OTA and find the approaches that reduce the neurotoxicity induced by OTA.

Abstract 89 | PDF Downloads 27 XML Downloads 0 HTML Downloads 2


Adler, M., Müller, K., Rached, E., Dekant, W. and Mally, A., 2009. Modulation of key regulators of mitosis linked to chromosomal instability is an early event in ochratoxin A carcinogenicity. Carcinogenesis 30: 711–719.
Agarwal, P., Singh, D., Raisuddin, S. and Kumar, R., 2020. Amelioration of ochratoxin-A induced cytotoxicity by prophylactic treatment of N-Acetyl-L-Tryptophan in human embryonic kidney cells. Toxicology 429: 152324.
Aimone, J.B., Wiles, J. and Gage, F.H., 2006. Potential role for adult neurogenesis in the encoding of time in new memories. Nature Neuroscience 9: 723.
Al-Anati, L. and Petzinger, E., 2006. Immunotoxic activity of ochratoxin A. Journal of Veterinary Pharmacology and Therapeutics 29: 79–90.
Aleo, M.D., Wyatt, R.D. and Schnellmann, R.G., 1991. Mitochondrial dysfunction is an early event in ochratoxin A but not oosporein toxicity to rat renal proximal tubules. Toxicology and Applied Pharmacology 107: 73–80.
Ariafar, S., Oftadeh Harsin, A., Fadaiie, A., Mahboobian, M.M. and Mohammadi, M., 2020. Toxicity effects of mycotoxins and autophagy: a mechanistic view. Toxin Reviews12: 1–11. http://
Babayan, N., Tadevosyan, G., Khondkaryan, L., Grigoryan, R., Sarkisyan, N., Haroutiounian, R. and Stopper, H., 2019. Ochratoxin A induces global DNA hypomethylation and oxidative stress in neuronal cells in vitro. Mycotoxin Research 36: 1–9.
Benesic, A., Mildenberger, S. and Gekle, M., 2000. Nephritogenic ochratoxin A interferes with hormonal signalling in immortalized human kidney epithelial cells. Pflügers Archiv 439: 278– 287.
Berger, V., Gabriel, A.-F., Sergent, T., Trouet, A., Larondelle, Y. and Schneider, Y.-J., 2003. Interaction of ochratoxin A with human intestinal Caco-2 cells: possible implication of a multidrug resistance-associated protein (MRP2). Toxicology Letters 140: 465– 476.
Biró, K., Solti, L., Barna-Vetró, I., Bagó, G., Glávits, R., Szabó, E. and Fink-Gremmels, J., 2002. Tissue distribution of ochratoxin A as determined by HPLC and ELISA and histopathological effects in chickens. Avian Pathology 31: 141–148.
Blanc, M., Pittet, A., Muñoz-Box, R. and Viani, R., 1998. Behavior of ochratoxin A during green coffee roasting and soluble coffee manufacture. Journal of Agricultural and Food Chemistry 46: 673–675.
Boesch-Saadatmandi, C., Loboda, A., Józkowicz, A., Huebbe, P., Blank, R., Wolffram, S., et al. 2008. Effect of ochratoxin A on redox-regulated transcription factors, antioxidant enzymes and glutathione-S-transferase in cultured kidney tubulus cells. Food and Chemical Toxicology 46: 2665–2671. http://dx.doi. org/10.1016/j.fct.2008.04.023
Boudra, H., Barnouin, J., Dragacci, S. and Morgavi, D., 2007. Aflatoxin M1 and ochratoxin A in raw bulk milk from French dairy herds. Journal of Dairy Science 90: 3197–3201. http://dx.
Cavin, C., Delatour, T., Marin-Kuan, M., Holzhäuser, D., Higgins, L., Bezencon, C., et al. 2006. Reduction in antioxidant defenses may contribute to ochratoxin A toxicity and carcinogenicity. Toxicological Sciences 96: 30–39. toxsci/kfl169
Chen, C. and Wu, F., 2017. The need to revisit ochratoxin A risk in light of diabetes, obesity, and chronic kidney disease prevalence. Food and Chemical Toxicology 103: 79–85. http://dx.doi. org/10.1016/j.fct.2017.03.001
Commission., C.A., 1998. Position paper on ochratoxin A. Food and Agriculture Organization of the United Nations, Rome, Italy, 1998. Available at: Chemicalcontaminants/ochratoxinpp99_14.
Coronel, M., Sanchis, V., Ramos, A. and Marin, S., 2010. Ochratoxin A: presence in human plasma and intake estimation. Food Science and Technology International 16: 5–18. http://dx.
Crago, B.R., Gray, M.R., Nelson, L.A., Davis, M., Arnold, L. and Thrasher, J.D., 2003. Psychological, neuropsychological, and electrocortical effects of mixed mold exposure. Archives of Environmental Health: An International Journal 58: 452–463.
Czerwiecki, L., 2001. Ochratoxin A and other mycotoxins in Polish cereals and foods. Mycotoxin Research 17: 125–128. http://dx.
Delibas, N., Altuntas, I., Yonden, Z. and Ozcelik, N., 2003. Ochratoxin A reduces NMDA receptor subunits 2A and 2B concentrations in rat hippocampus: partial protective effect of melatonin. Human & Experimental Toxicology 22: 335–339.
Dhanshetty, M. and Banerjee, K., 2019. Simultaneous direct analysis of aflatoxins and ochratoxin A in cereals and their processed products by ultra-high performance liquid chromatography with fluorescence detection. Journal of AOAC International. 6:1666-1672.
Duarte, S., Pena, A. and Lino, C., 2010. A review on ochratoxin A occurrence and effects of processing of cereal and cereal derived food products. Food Microbiology 27: 187–198. http://dx.doi. org/10.1016/
FAO, 2004. Worldwide regulations for mycotoxins in food and feed in 2003. Available at: asp?url_file=/docrep/007/y5499e/y5499e0f.htmFAO, 2005. Reducing ochratoxin A in coffee. Available at:
Fazekas, B., Tar, A. and Zomborszky-Kovács, M., 2002. Ochratoxin  A contamination of cereal grains and coffee in Hungary in the year 2001. Acta Veterinaria Hungarica 50: 177–188.
Frisvad, J.C., Møller, L.L., Larsen, T.O., Kumar, R. and Arnau, J., 2018. Safety of the fungal workhorses of industrial biotechnology: update on the mycotoxin and secondary metabolite potential of Aspergillus niger, Aspergillus oryzae, and Trichoderma reesei. Applied Microbiology and Biotechnology 102: 9481– 9515.
Fuchs, E., Binder, E., Schatzmayr, G., Heidler, D., Klimitsch, A. and Krska, R., 2001. Monitoring of residues of ochratoxin A in blood and kidney of chicken using HPLC-FLD. Mycotoxin Research 17: 142–145.
Galtier, P., Alvinerie, M. and Charpenteau, J., 1981. The pharmacokinetic profiles of ochratoxin A in pigs, rabbits and chickens. Food and Cosmetics Toxicology 19: 735–738.
Gautier, J.-C., Holzhaeuser, D., Markovic, J., Gremaud, E., Schilter,  B.T. and Turesky, R.J., 2001. Oxidative damage and stress response from ochratoxin A exposure in rats. Free Radical Biology and Medicine 30: 1089–1098.
Gekle, M., Schwerdt, G., Freudinger, R., Mildenberger, S., Wilflingseder, D., Pollack, V., et al. 2000. Ochratoxin A induces JNK activation and apoptosis in MDCK-C7 cells at nanomo-lar concentrations. Journal of Pharmacology and Experimental Therapeutics 293: 837–844.
Gordon, W.A. and Cantor, J.B., 2004. The diagnosis of cognitive impairment associated with exposure to mold. Advances in Applied Microbiology 55: 361. S0065-2164(04)55014-1
Hameed, M.R., Khan, M.Z., Saleemi, M.K., Khan, A., Akhtar, M., Hassan, Z.-U. and Hussain, Z., 2017. Study of ochratoxin A (OTA)-induced oxidative stress markers in broiler chicks. Toxin Reviews 36: 270–274. .1303780
Heussner, A.H. and Bingle, L.E., 2015. Comparative ochratoxin toxicity: a review of the available data. Toxins 7: 4253–4282.
Hong, J.T., Lee, M.K., Park, K.S., Jung, K.M., Lee, R.D., Jung, H.K., et al. 2002. Inhibitory effect of peroxisome proliferator-activated receptor gamma agonist on ochratoxin A-induced cytotoxicity and activation of transcription factors in cultured rat embryonic midbrain cells. Journal of Toxicology and Environmental Health Part A 65: 407–418.
Horvath, A., Upham, B.L., Ganev, V. and Trosko, J.E., 2002. Determination of the epigenetic effects of ochratoxin in a human kidney and a rat liver epithelial cell line. Toxicon 40: 273–282.
Hsieh, M.F., Chiu, H.Y., Lin-Tan, D.T. and Lin, J.L., 2004. Does human ochratoxin A aggravate proteinuria in patients with chronic renal disease? Renal Failure 26: 311–316. http://dx.doi. org/10.1081/JDI-200026744
Huffman, J., Gerber, R. and Du, L., 2010. Recent advancements in the biosynthetic mechanisms for polyketide-derived mycotoxins. Biopolymers 93: 764–776.
Huong, B.T.M., Tuyen, L.D., Madsen, H., Brimer, L., Friis, H. and Dalsgaard, A., 2019. Total dietary intake and health risks associated with exposure to aflatoxin B1, ochratoxin A and fuminisins of children in Lao Cai Province, Vietnam. Toxins 11: 638.
Il’ichev, Y.V., Perry, J.L. and Simon, J.D., 2002. Interaction of ochratoxin A with human serum albumin. Preferential binding of the dianion and pH effects. The Journal of Physical Chemistry B 106: 452–459.
Iriondo-DeHond, A., Garcia, N.A., Fernandez-Gomez, B., Guisantes-Batan, E., Escobar, F.V., Blanch, G.P., et al. 2019. Validation of coffee by-products as novel food ingredients. Innovative Food Science & Emerging Technologies 51: 194–204.
Jung, K.Y., Takeda, M., Kim, D.K., Tojo, A., Narikawa, S., Yoo, B.S., et al. 2001. Characterization of ochratoxin A transport by human organic anion transporters. Life Sciences 69: 2123–2135.
Köhler, H., Heller, M., Erler, W., Müller, G., Rosner, H. and Gräfe, U., 2002. Effect of ochratoxin A and ochratoxin C on the monocyte and lymphocyte function. Mycotoxin Research 18: 169–172.
Lagace, D.C., Yee, J.K., Bolaños, C.A. and Eisch, A.J., 2006. Juvenile administration of methylphenidate attenuates adult hippocampal neurogenesis. Biological Psychiatry 60: 1121–1130. http://
Lee, H.J., Gu, B.-J., Ganjyal, G. and Ryu, D., 2019. Reduction of ochratoxin A in direct steam injected oat-based infant cereals with baking soda. Food Control 96: 441–444. http://dx.doi. org/10.1016/j.foodcont.2018.10.001
Leier, I., Hummel-Eisenbeiss, J., Cui, Y. and Keppler, D., 2000. ATP-dependent para-aminohippurate transport by apical multidrug resistance protein MRP2. Kidney International 57: 1636–1642.
Limonciel, A. and Jennings, P., 2014. A review of the evidence that ochratoxin A is an Nrf2 inhibitor: implications for nephrotoxicity and renal carcinogenicity. Toxins 6: 371–379. http://dx.doi. org/10.3390/toxins6010371
Lioi, M., Santoro, A., Barbieri, R., Salzano, S. and Ursini, M., 2004. Ochratoxin A and zearalenone: a comparative study on genotoxic effects and cell death induced in bovine lymphocytes. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 557: 19–27.
Lühe, A., Hildebrand, H., Bach, U., Dingermann, T. and Ahr, H.-J., 2003. A new approach to studying ochratoxin A (OTA)-induced nephrotoxicity: expression profiling in vivo and in vitro employing cDNA microarrays. Toxicological Sciences 73: 315–328.
Lund, F. and Frisvad, J.C., 2003. Penicillium verrucosum in wheat and barley indicates presence of ochratoxin A. Journal of Applied Microbiology 95: 1117–1123. http://dx.doi. org/10.1046/j.1365-2672.2003.02076.x
Magan, N. and Aldred, D., 2005. Conditions of formation of ochratoxin A in drying, transport and in different commodities. Food Additives and Contaminants 22: 10–16. http://dx.doi. org/10.1080/02652030500412154
Magan, N. and Aldred, D., 2007. Why do fungi produce mycotoxins? Mycology Series 25: 121.
Mally, A., 2012. Ochratoxin A and mitotic disruption: mode of action analysis of renal tumor formation by ochratoxin A. Toxicological Sciences 127: 315–330. toxsci/kfs105
Maresca, M., Mahfoud, R., Pfohl-Leszkowicz, A. and Fantini, J., 2001. The mycotoxin ochratoxin A alters intestinal barrier and absorption functions but has no effect on chloride secretion. Toxicology and Applied Pharmacology 176: 54–63.
Marin-Kuan, M., Nestler, S., Verguet, C., Bezencon, C., Piguet, D., Mansourian, R., et al. 2005. A toxicogenomics approach to identify new plausible epigenetic mechanisms of ochratoxin A car-cinogenicity in rat. Toxicological Sciences 89: 120–134.
Novak, I., 2012. Mitophagy: a complex mechanism of mitochondrial removal. Antioxidants & Redox Signaling 17: 794–802.
Otteneder, H. and Majerus, P., 2000. Ochratoxin A in Kaffee: Bundesweite Auswertung von Daten der Lebensmittelüberwachung der Jahre 1995 bis 1999. Mycotoxin Research 16: 131–131.
Pagliassotti, M.J., Kim, P.Y., Estrada, A.L., Stewart, C.M. and Gentile, C.L., 2016. Endoplasmic reticulum stress in obesity and obesity-related disorders: an expanded view. Metabolism 65: 1238–1246.
Park, S., Lim, W., You, S. and Song, G., 2019. Ochratoxin A exerts neurotoxicity in human astrocytes through mitochondria-dependent apoptosis and intracellular calcium overload. Toxicology Letters 313: 42–49.
Perry, J.L., Goldsmith, M.R., Peterson, M.A., Beratan, D.N., Wozniak, G., et al. 2004. Structure of the ochratoxin A binding site within human serum albumin. The Journal of Physical Chemistry B 108: 16960–16964.
Perry, J.L., Il’ichev, Y.V., Kempf, V.R., McClendon, J., Park, G., Manderville, R.A., Rüker, F., Dockal, M. and Simon, J.D., 2003. Binding of ochratoxin A derivatives to human serum albumin. The Journal of Physical Chemistry B 107: 6644–6647.
Petzinger, E. and Ziegler, K., 2000. Ochratoxin A from a toxicological perspective. Journal of Veterinary Pharmacology and Therapeutics 23: 91–98. 2000.00244.x
Pfohl-Leszkowicz, A. and Manderville, R.A., 2007. Ochratoxin A: an overview on toxicity and carcinogenicity in animals and humans. Molecular Nutrition & Food Research 51: 61–99.
Pitt, J., 2000. Toxigenic fungi and mycotoxins. British Medical Bulletin 56: 184–192.
Poor, M., Kuzma, M., Matisz, G., Li, Y., Perjesi, P., Kunsagi-Mate, S. and K?szegi, T., 2014. Further aspects of Ochratoxin A-cation interactions: complex formation with zinc ions and a novel analytical application of ochratoxin A-magnesium interaction in the HPLC-FLD system. Toxins 6: 1295–1307. http://dx.doi. org/10.3390/toxins6041295
Qi, X., Yu, T., Zhu, L., Gao, J., He, X., Huang, K., et al. 2014. Ochratoxin A induces rat renal carcinogenicity with limited induction of oxi-dative stress responses. Toxicology and Applied Pharmacology 280: 543–549.
Ranaldi, G., Caprini, V., Sambuy, Y., Perozzi, G. and Murgia, C., 2009. Intracellular zinc stores protect the intestinal epithelium from Ochratoxin A toxicity. Toxicology in Vitro 23: 1516–1521.
Ricci, F.G., Terkelli, L.R., Venancio, E.J., Justino, L., Dos Santos, B.Q., Baptista, A.A.S., et al. 2021. Tryptophan attenuates the effects of OTA on intestinal morphology and local IgA/IgY produc-tion in broiler chicks. Toxins 13: 5.
Rindi, G., Klimstra, D.S., Abedi-Ardekani, B., Asa, S.L., Bosman, F.T., Brambilla, E., et al. 2018. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Modern Pathology 31: 1770–1786.
Romani, S., Sacchetti, G., Chaves López, C., Pinnavaia, G.G. and Dalla Rosa, M., 2000. Screening on the occurrence of ochratoxin A in green coffee beans of different origins and types. Journal of Agricultural and Food Chemistry 48: 3616–3619.
Ropejko, K. and Twaru?ek, M., 2019. The occurrence of ochratoxin A in human body fluids–review. Toxin Reviews 23: 1–14.
Sava, V., Reunova, O., Velasquez, A., Harbison, R. and Sanchez-Ramos, J., 2006. Acute neurotoxic effects of the fungal metabolite ochratoxin-A. Neurotoxicology 27: 82–92. http://dx.doi. org/10.1016/j.neuro.2005.07.004
Sava, V., Velasquez, A., Song, S. and Sanchez-Ramos, J., 2007. Adult hippocampal neural stem/progenitor cells in vitro are vulnerable to the mycotoxin ochratoxin-A. Toxicological Sciences 98: 187–197.
Schaaf, G., Nijmeijer, S., Maas, R., Roestenberg, P., De Groene,  E. and Fink-Gremmels, J., 2002. The role of oxidative stress in the ochratoxin A-mediated toxicity in proximal tubular cells. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1588: 149–158. S0925-4439(02)00159-X
Schrickx, J., Lektarau, Y. and Fink-Gremmels, J., 2006. Ochratoxin A secretion by ATP-dependent membrane transporters in Caco-2 cells. Archives of Toxicology 80: 243–249. http://dx.doi. org/10.1007/s00204-005-0041-5
Seabra, A.B., Rolim, W.R. and Pieretti, J.C., 2020. Potent application of nitric oxide–releasing nanomaterials against toxigenic fungi and their mycotoxins. In: Nanomycotoxicology. Elsevier, pp. 481–501.
Shen, X.L., Zhang, B., Liang, R., Cheng, W.-H., Xu, W., Luo, Y., et al. 2014. Central role of nix in the autophagic response to ochratoxin A. Food and Chemical Toxicology 69: 202–209. http://dx.
Skaug, M.A., Helland, I., Solvoll, K. and Saugstad, O.D., 2001. Presence of ochratoxin A in human milk in relation to dietary intake. Food Additives & Contaminants 18: 321–327. http://dx.
Sorrenti, V., Di Giacomo, C., Acquaviva, R., Barbagallo, I., Bognanno, M. and Galvano, F., 2013. Toxicity of ochratoxin a and its modulation by antioxidants: a review. Toxins 5: 1742– 1766.
Studer-Rohr, I., Schlatter, J. and Dietrich, D.R., 2000. Kinetic parameters and intraindividual fluctuations of ochratoxin A plasma levels in humans. Archives of Toxicology 74: 499–510. http://
Sueck, F., Specht, J., Cramer, B. and Humpf, H.-U., 2019. Identification of ochratoxin-N-acetyl-L-cysteine as a new ochratoxin A metabolite and potential biomarker in human urine. Mycotoxin Research 36: 1–10. s12550-019-00360-0
Uetsuka, K., 2011. Mechanisms of mycotoxin-induced neurotoxicity through oxidative stress-associated pathways. International Journal of Molecular Sciences 12: 5213–5237. http://dx.doi. org/10.3390/ijms12085213
van der Stegen, G.H., Essens, P.J. and van der Lijn, J., 2001. Effect of roasting conditions on reduction of ochratoxin A in coffee. Journal of Agricultural and Food Chemistry 49: 4713–4715.
Weidenbach, A., Schuh, K., Failing, K. and Petzinger, E., 2000. Ochratoxin A induced TNF? release from the isolated and blood-free perfused rat liver. Mycotoxin Research 16: 189–193.
Xing, Y., Yang, S.-D., Wang, M.-M., Feng, Y.-S., Dong, F. and Zhang, F., 2019. The beneficial roles of exercise training via autophagy in neurological diseases and possible mechanisms. Life Sciences 15:130-134
Xiong, K., Zhi, H.-W., Liu, J.-Y., Wang, X.-Y., Zhao, Z.-Y., Pei, P.-G., et al. 2020. Detoxification of ochratoxin A by a novel aspergillus oryzae strain and optimization of its biodegradation. Revista Argentina de Microbiología 53:48-54.
Yoon, S., Cong, W.-T., Bang, Y., Lee, S.N., Yoon, C.S., Kwack,  S.J., et  al. 2009. Proteome response to ochratoxin A-induced apoptotic cell death in mouse hippocampal HT22 cells. Neurotoxicology 30: 666–676.
Yu, J., Mikiashvili, N. and Liang, C.L., 2019. Deoxynivalenol and ochratoxin A in North Carolina grown organic wheat grains. Journal of Food Safety e12687 5:17–170. http://dx.doi. org/10.1111/jfs.12687
Zhang, X., Boesch-Saadatmandi, C., Lou, Y., Wolffram, S., Huebbe, P. and Rimbach, G., 2009. Ochratoxin A induces apopto-sis in neuronal cells. Genes & Nutrition 4: 41. http://dx.doi. org/10.1007/s12263-008-0109-y
Zhu, L., Zhang, B., Dai, Y., Li, H. and Xu, W., 2017. A review: epigenetic mechanism in ochratoxin a toxicity studies. Toxins 9: 113.